Alumis receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alumis Inc (ALMS)
Alumis Inc stock price live, this page displays NASDAQ ALMS stock exchange data. View the ALMS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Alumis Inc real time stock price chart below.
What Is the Alumis Inc Stock Price Today?
The Alumis Inc stock price today is 22.02.
What Is the Stock Symbol for Alumis Inc?
The stock symbol for Alumis Inc is "ALMS."
What Stock Exchange Does Alumis Inc Trade On?
Alumis Inc is listed and trades on the NASDAQ stock exchange.
Is Alumis Inc a Good Stock to Buy?
Determining whether Alumis Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALMS quote. (ISIN: US0223071020) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
What Is the Alumis Inc Stock Price Today?
The Alumis Inc stock price today is 22.02.
What Is the Stock Symbol for Alumis Inc?
The stock symbol for Alumis Inc is "ALMS."
What Stock Exchange Does Alumis Inc Trade On?
Alumis Inc is listed and trades on the NASDAQ stock exchange.
Is Alumis Inc a Good Stock to Buy?
Determining whether Alumis Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALMS quote. (ISIN: US0223071020) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
Fair Value
An estimate of a Alumis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.73
22.72
52 wk Range
2.76
30.60
ALMS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Alumis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.7322.72
52 wk Range
2.7630.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALMS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Alumis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
40.10
Upside
+82.11%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
- Alumis receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Alumis receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Alumis receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell
Analyst Ratings
10 Buy
1 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 40.10
(+82.11% Upside)
Earnings
Latest Release
May 14, 2026
EPS / Forecast
-0.74 / --
Revenue / Forecast
1.74M / --
Compare ALMS to Peers and Sector
Metrics to compare | ALMS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALMSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.8x | −3.0x | −0.5x | |
PEG Ratio | −0.16 | −0.01 | 0.00 | |
Price/Book | 5.0x | 1.8x | 2.6x | |
Price / LTM Sales | 334.1x | 16.5x | 3.1x | |
Upside (Analyst Target) | 79.7% | 25.8% | 53.0% | |
Fair Value Upside | Unlock | −5.1% | 6.3% | Unlock |
Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. Alumis Inc. was incorporated in 2021 and is headquartered in South San Francisco, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Alumis (ALMS) Stock Price Today?
The Alumis stock price today is 22.02 USD.
What Stock Exchange Does Alumis Trade On?
Alumis is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Alumis?
The stock symbol for Alumis is "ALMS."
What Is the Alumis (ALMS) Afterhours Price Today? (Afterhours variable test: 21.80) Current Date: May 23, 2026
After hours price: 21.80. After hours price change (units): -0.22. Price change percentage: -1.00%
What Is the Alumis Market Cap?
As of today, Alumis market cap is 2.81B USD.
What Is Alumis's Earnings Per Share (TTM)?
The Alumis EPS (TTM) is -2.31.
When Is the Next Alumis Earnings Date?
Alumis will release its next earnings report on Aug 19, 2026.
From a Technical Analysis Perspective, Is ALMS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Alumis Stock Split?
Alumis has split 0 times.
How Many Employees Does Alumis Have?
Alumis has 226 employees.
What is the current trading status of Alumis (ALMS)?
As of May 23, 2026, Alumis (ALMS) is trading at a price of 22.02 USD, with a previous close of 22.17 USD. The stock has fluctuated within a day range of 21.73 USD to 22.72 USD, while its 52-week range spans from 2.76 USD to 30.60 USD.
What Is Alumis (ALMS) Price Target According to Analysts?
The average 12-month price target for Alumis is 40.10 USD, with a high estimate of 55 USD and a low estimate of 25 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +82.11% Upside potential.
What Is the ALMS Premarket Price?
ALMS's last pre-market stock price is 22.00 USD. The pre-market share volume is 320.00, and the stock has decreased by -0.17, or -0.77%.
What Is the ALMS After Hours Price?
ALMS's last after hours stock price is 21.80 USD, the stock has decreased by -0.22, or -1.00%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.